The 23


Supporting innovation - more biopharmaceuticals for less

RapidAim logo


Alinta Furnell COO

Ismat Kabbara CEO & CSO

Get in Contact

Synbiote is a biotechnology startup aiming to accelerate the research and development of novel biopharmaceutical products such as vaccines, chemotherapy drugs, and hormones.
They are developing a machine that will automate key production processes to save researchers both time and money in development. Accelerating the R&D of these biopharmaceuticals means that they will be cheaper to produce, and faster to get to market.

What deeptech innovation excites you?

Synthetic biology! Now more than ever, biotechnology has begun to form the foundation of many leading innovations. It’s so exciting to see how inspiration can be taken from nature and applied to benefit our daily lives.


Alinta Furnell

COO, Synbiote

With a specialisation in microbiology, Alinta Furnell has a strong understanding of both the research and commercialisation aspects of biotechnology.

Alinta has had a diverse range of both industry and entrepreneurial experience across a variety of positions involving product development, scientific research, project management, and advisory. Alinta has previously worked with HCF Health Insurance Australia, UNSW, The George Institute and the Michael Crouch Innovation Centre to both develop and commercialise breakthrough technology in the biotechnology and medtech field.

Alinta is passionate about bridging the gap between research and commercialisation and strives to bring accessible solutions into the lives of those who need them most.

tech 23 dots

If your company had a theme song, what would it be and why?

Move on Up – Curtis Mayfield. As co-founders, resilience and the willingness to constantly learn and develop your skills is so important!

Check out the rest of The 23…